Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Jan 1;101(1):273–281. doi: 10.1172/JCI1316

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

G A Schellekens 1, B A de Jong 1, F H van den Hoogen 1, L B van de Putte 1, W J van Venrooij 1
PMCID: PMC508564  PMID: 9421490

Abstract

Only a few autoantibodies that are more or less specific for RA have been described so far. The rheumatoid factor most often tested for is not very specific for RA, while the more specific antiperinuclear factor for several reasons is not routinely used as a serological parameter. Here we show that autoantibodies reactive with synthetic peptides containing the unusual amino acid citrulline, a posttranslationally modified arginine residue, are specifically present in the sera of RA patients. Using several citrulline-containing peptide variants in ELISA, antibodies could be detected in 76% of RA sera with a specificity of 96%. Sera showed a remarkable variety in the reactivity pattern towards different citrulline-containing peptides. Affinity-purified antibodies were shown to be positive in the immunofluorescence-based antiperinuclear factor test, and in the so-called antikeratin antibody test, and were reactive towards filaggrin extracted from human epidermis. The specific nature of these antibodies and the presence of these antibodies early in disease, even before other disease manifestations occur, are indicative for a possible role of citrulline-containing epitopes in the pathogenesis of RA.

Full Text

The Full Text of this article is available as a PDF (454.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  2. Boers M., Verhoeven A. C., Markusse H. M., van de Laar M. A., Westhovens R., van Denderen J. C., van Zeben D., Dijkmans B. A., Peeters A. J., Jacobs P. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet. 1997 Aug 2;350(9074):309–318. doi: 10.1016/S0140-6736(97)01300-7. [DOI] [PubMed] [Google Scholar]
  3. Dyson H. J., Wright P. E. Antigenic peptides. FASEB J. 1995 Jan;9(1):37–42. doi: 10.1096/fasebj.9.1.7821757. [DOI] [PubMed] [Google Scholar]
  4. Gan S. Q., McBride O. W., Idler W. W., Markova N., Steinert P. M. Organization, structure, and polymorphisms of the human profilaggrin gene. Biochemistry. 1990 Oct 9;29(40):9432–9440. doi: 10.1021/bi00492a018. [DOI] [PubMed] [Google Scholar]
  5. Garnier J., Osguthorpe D. J., Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol. 1978 Mar 25;120(1):97–120. doi: 10.1016/0022-2836(78)90297-8. [DOI] [PubMed] [Google Scholar]
  6. Gregersen P. K., Silver J., Winchester R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987 Nov;30(11):1205–1213. doi: 10.1002/art.1780301102. [DOI] [PubMed] [Google Scholar]
  7. Harding C. R., Scott I. R. Histidine-rich proteins (filaggrins): structural and functional heterogeneity during epidermal differentiation. J Mol Biol. 1983 Nov 5;170(3):651–673. doi: 10.1016/s0022-2836(83)80126-0. [DOI] [PubMed] [Google Scholar]
  8. Hoet R. M., Boerbooms A. M., Arends M., Ruiter D. J., van Venrooij W. J. Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin. Ann Rheum Dis. 1991 Sep;50(9):611–618. doi: 10.1136/ard.50.9.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jameson B. A., Wolf H. The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci. 1988 Mar;4(1):181–186. doi: 10.1093/bioinformatics/4.1.181. [DOI] [PubMed] [Google Scholar]
  10. Kurki P., Aho K., Palosuo T., Heliövaara M. Immunopathology of rheumatoid arthritis. Antikeratin antibodies precede the clinical disease. Arthritis Rheum. 1992 Aug;35(8):914–917. doi: 10.1002/art.1780350810. [DOI] [PubMed] [Google Scholar]
  11. Mack J. W., Steven A. C., Steinert P. M. The mechanism of interaction of filaggrin with intermediate filaments. The ionic zipper hypothesis. J Mol Biol. 1993 Jul 5;232(1):50–66. doi: 10.1006/jmbi.1993.1369. [DOI] [PubMed] [Google Scholar]
  12. McKinley-Grant L. J., Idler W. W., Bernstein I. A., Parry D. A., Cannizzaro L., Croce C. M., Huebner K., Lessin S. R., Steinert P. M. Characterization of a cDNA clone encoding human filaggrin and localization of the gene to chromosome region 1q21. Proc Natl Acad Sci U S A. 1989 Jul;86(13):4848–4852. doi: 10.1073/pnas.86.13.4848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. NIENHUIS R. L., MANDEMA E. A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR. Ann Rheum Dis. 1964 Jul;23:302–305. doi: 10.1136/ard.23.4.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nagata S., Senshu T. Peptidylarginine deiminase in rat and mouse hemopoietic cells. Experientia. 1990 Jan 15;46(1):72–74. doi: 10.1007/BF01955420. [DOI] [PubMed] [Google Scholar]
  15. Paimela L., Gripenberg M., Kurki P., Leirisalo-Repo M. Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis. 1992 Jun;51(6):743–746. doi: 10.1136/ard.51.6.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Schellekens G. A., Lasonder E., Feijlbrief M., Koedijk D. G., Drijfhout J. W., Scheffer A. J., Welling-Wester S., Welling G. W. Identification of the core residues of the epitope of a monoclonal antibody raised against glycoprotein D of herpes simplex virus type 1 by screening of a random peptide library. Eur J Immunol. 1994 Dec;24(12):3188–3193. doi: 10.1002/eji.1830241241. [DOI] [PubMed] [Google Scholar]
  17. Sebbag M., Simon M., Vincent C., Masson-Bessière C., Girbal E., Durieux J. J., Serre G. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1995 Jun;95(6):2672–2679. doi: 10.1172/JCI117969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Simon M., Girbal E., Sebbag M., Gomès-Daudrix V., Vincent C., Salama G., Serre G. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. J Clin Invest. 1993 Sep;92(3):1387–1393. doi: 10.1172/JCI116713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tarcsa E., Marekov L. N., Mei G., Melino G., Lee S. C., Steinert P. M. Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem. 1996 Nov 29;271(48):30709–30716. doi: 10.1074/jbc.271.48.30709. [DOI] [PubMed] [Google Scholar]
  20. Utz P. J., Hottelet M., Schur P. H., Anderson P. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med. 1997 Mar 3;185(5):843–854. doi: 10.1084/jem.185.5.843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Vincent C., Serre G., Lapeyre F., Fournié B., Ayrolles C., Fournié A., Soleilhavoup J. P. High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called 'antikeratin antibodies'. Ann Rheum Dis. 1989 Sep;48(9):712–722. doi: 10.1136/ard.48.9.712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Westgeest A. A., Boerbooms A. M., Jongmans M., Vandenbroucke J. P., Vierwinden G., van de Putte L. B. Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis. J Rheumatol. 1987 Oct;14(5):893–897. [PubMed] [Google Scholar]
  23. Williamson M. P., Handa B. K., Hall M. J. Secondary structure of a herpes simplex virus glycoprotein D antigenic domain. Int J Pept Protein Res. 1986 May;27(5):562–568. [PubMed] [Google Scholar]
  24. Young B. J., Mallya R. K., Leslie R. D., Clark C. J., Hamblin T. J. Anti-keratin antibodies in rheumatoid arthritis. Br Med J. 1979 Jul 14;2(6182):97–99. doi: 10.1136/bmj.2.6182.97. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES